2022
DOI: 10.1089/scd.2022.0060
|View full text |Cite
|
Sign up to set email alerts
|

Methodological Quality and Risk of Bias of Systematic Reviews and Meta-Analyses on Stem Cells for Knee Osteoarthritis: A Cross-Sectional Survey

Abstract: Background: Clinical guidelines need high-quality studies to support clinical decision-making, in which the evidence often was collected from systematic reviews (SRs) and/or meta-analyses (MAs). At present, the methodological quality and risk of bias (RoB) of SRs/MAs on stem cell therapy for the treatment of knee osteoarthritis (KOA) has been poorly investigated. This study aims to strictly evaluate the methodological quality and RoB in SRs/MAs of stem cell therapy for KOA.Methods: Four electronic databases (P… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 98 publications
0
2
0
Order By: Relevance
“…This may be because PRISMA reporting specification merely provides researchers with a checklist of items to report while they themselves determine the actual content and level of detail of the final report. Additionally, the list of excluded studies and their reasons, and the early registration of protocols, had a substantial effect on the methodological quality of SRs/MAs [ 126 ], but few studies followed guidelines by registering protocols, establishing PICOs, and providing lists of excluded papers. According to AMSTAR 2 and PRISMA guidelines, relying solely on electronic database searches is insufficient.…”
Section: Discussionmentioning
confidence: 99%
“…This may be because PRISMA reporting specification merely provides researchers with a checklist of items to report while they themselves determine the actual content and level of detail of the final report. Additionally, the list of excluded studies and their reasons, and the early registration of protocols, had a substantial effect on the methodological quality of SRs/MAs [ 126 ], but few studies followed guidelines by registering protocols, establishing PICOs, and providing lists of excluded papers. According to AMSTAR 2 and PRISMA guidelines, relying solely on electronic database searches is insufficient.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the studies we included did not report or underreported some features related to reporting methodological quality (concealed allocation, blinding, intention to treat, power analysis) according to CONSORT checklists. Articles with low methodological quality tend to exaggerate treatment effects and have a high risk of bias [28,29].…”
Section: Discussionmentioning
confidence: 99%